生物荧光体外抗肿瘤药敏检测技术主要临床研究文献Word文件下载.doc
《生物荧光体外抗肿瘤药敏检测技术主要临床研究文献Word文件下载.doc》由会员分享,可在线阅读,更多相关《生物荧光体外抗肿瘤药敏检测技术主要临床研究文献Word文件下载.doc(6页珍藏版)》请在冰豆网上搜索。
11(3):
274-277.
4、SevinBU,PengZL,etal.ApplicationofanATP-bioluminescenceassayinhumantumorchemosensitivitytesting.GynecolOncol.1988Sep;
31
(1):
191-204.
乳腺癌(BreastCancer)
5、IanACree,ChristianMKurbacher,etal.Correlationoftheclinicalresponsetochemotherapyinbreastcancerwithexvivochemosensitivity.Anti-cancerDrug1996,7,pp.630-635.
6、KoechliOR,AvnerBP,etal.Applicationoftheadenosinetriphosphate-cellviabilityassayinhumanbreastcancerchemosensitivitytesting:
areportonthefirstresults.JSurgOncol.1993Oct;
54
(2):
119-25.
7、KurbacherCM,GrecuOM,etal.ATPchemosensitivitytestinginovarianandbreastcancer:
earlyclinicaltrials.RecentResultsCancerRes.2003;
161:
221-30.
消化道肿瘤(GastrointestinalCancer)
8、H.Kawamura,K.Ikeda,etal.TheusefulnessoftheATPassaywithserum-freecultureforchemosensitivitytestingofgastrointestinalcancer.EuropeanJournalofcancervol33,No.6,pp.960-966,1997.
9、MercerSJ,SomersSS,etal.Heterogeneityofchemosensitivityofesophagealandgastriccarcinoma.AnticancerDrugs.2003Jul;
14(6):
397-403.
10、JinushiK,HirabayashiN,etal.ClinicalstudiesofinvitrochemosensitivitytestevaluatedbyATPassayofgastrointestinalcancer.GanToKagakuRyoho.1990Nov;
17(11):
2235-9.
11、褚忠华王捷等.体外药敏试验ATP-TCA在消化系恶性实体肿瘤化疗中的应用.2002;
22(7):
418-420.
结肠癌(ColorectalCancer)
12、WhitehousePA,KnightLA,etal.HeterogeneityofchemosensitivityofcolorectaladenocarcinomadeterminedbyamodifiedexvivoATP-tumorchemosensitivityassay(ATP-TCA).AnticancerDrugs.2003Jun;
14(5):
369-75.
泌尿系肿瘤(UrogenitalTumor)
13、YamadaS,DeguchiT,etal.StudyonchemosensitivitytestofurogenitaltumorsbyATPassay.NipponHinyokikaGakkaiZasshi.1992Dec;
83(12):
2022-8.
卵巢癌(OvarianCancer)
14、PeterE.Andreotti,IanA.cree,etal.Chemosensitivitytestingofhumantumorsusingamicroplateadenosinetriphosphateluminescenceassay:
clinicalcorrelationforcisolatinresisitanceofovariancarcinoma.Cancerresearch1995,55,5276-5282.
15、KurbacherCM,CreeIA,etal.UseofanexvivoATPluminescenceassaytodirectchemotherapyforrecurrentovariancancer.AnticancerDrugs.1998Jan;
9
(1):
51-7.
16、AnneT.O’Meara,M.D.,Berand-UweSevin,M.D.PredictivevalueoftheATPchemosensitivityassayinEpithelialovariancancer.GynecolOncol.2001Nov;
83
(2):
334-42.
17、KonecnyG,CrohnsC,etal.CorrelationofdrugresponsewiththeATPtumorchemosensitivityassayinprimaryFIGOstageIIIovariancancer.GynecolOncol.2000May;
77
(2):
258-63.
18、BreidenbachM,ReinDT,etal.Individualizedlongtermchemotherapyforrecurrentovarianafterfailinghigh-dosetreatment.Anticancerdrugs.2002,13
(2):
173-176.
19、OutcomeofATPbasedtumorchemosensitivityassaydirededchemotherapyinheavilypre-treatedrecurrent.OvarianCarcinoma.BMCcancer.2003;
3
(1):
19.
20、韩国荣沈玲等.ATP体外药敏试验指导的卵巢癌预见性化疗.现代医学.2003;
31(3):
148-150.
21、张凯、章文华等.ATP生物荧光法在卵巢癌体外药敏检测中的应用.癌症进展2003;
1
(1):
37-41.
22、刘珊玲、彭兰芝等.ATP-生物荧光法在肿瘤体外药物敏感性试验中的应用研究.华西医科大学.2000;
31(3):
330-333.
23、楼江燕彭芝兰等.三磷酸腺苷生物发光法在卵巢癌体外化疗药物敏感性试验中的应用.华西医科大学报.2000;
31(4):
553-556.
24、韩国荣张林等.人卵巢癌原代培养体外药敏试验的评价.中国肿瘤临床与康复.1999;
6(5):
21-23.
膀胱癌(BladderCancer)
25、InoueK,KasaharaK,etal.TheefficacyofATPSensitivityassayonintravesicalprophylacticinstillationforsuperficialbladdercancer.NipponHinyokikaGakkaiZasshi,1996,87(12):
1281.
肝癌(LiverCancer)
26、褚忠华陈涛等.肿瘤体外药敏检测三磷酸腺苷生物发光法在肝癌化疗中的应用.中华实验骨科杂志.2002;
19(3):
235-236.
白血病(Leukemia)
27、王琳秦叔逮等.急性白血病化疗药物敏感性-ATP法的临床应用.肿瘤防治研究.1996;
23
(1):
114-115.
黑色素瘤(Melanoma)
28、IanACree,MichaelHneale,etal.Heterogeneityofchemosensitivityofmetastaticcutaneousmelanoma.AnticancerDrugs.1999Jun;
10pp:
437-444.
29、MyattN,CreeIA,etal.Theexvivochemosensitivityprofileofchoroidalmelanoma.AnticancerDrugs.1997Sep;
8(8):
756-62.